Working groups
Sandra is a long-term member of the Immune Therapies group and has worked with Professor Hogarth since 1996.
She is part of the Cancer, Inflammation and Infectious Diseases projects which focus on antibody and Fc receptor therapeutic research and development. She also worked with Professor Geoff Pietersz from 1998 to 2014 focusing on antibody-drug conjugate therapeutic research and development.
Immunological Reviews
Clarissa A. Whitehead, Bruce D. Wines, Halina M. Trist, Sandra Esparon, P. Mark Hogarth
Immunology and Cell Biology
Alicia M. Chenoweth, Sandra Esparon, Bruce D. Wines, P. Mark Hogarth
Frontiers in Immunology
Bruce D. Wines, Liriye Kurtovic, Halina M. Trist, Sandra Esparon, Klasina Chappin, James G. Beeson, P. Mark Hogarth
We've discovered how to selectively engage and ‘switch off’ the cells that initiate and drive inflammation, targeting specific inflammatory cells in autoimmune and allergic diseases.
Stellabody® is up to 100 times more effective at cell killing than standard antibody therapeutics.